Literature DB >> 8723138

Clinical course of patients with idiopathic Parkinson's disease.

R A Roos1, J C Jongen, E A van der Velde.   

Abstract

We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, initial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia-free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased from the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723138     DOI: 10.1002/mds.870110304

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.

Authors:  M A Hely; J G Morris; R Traficante; W G Reid; D J O'Sullivan; P M Williamson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Parkinson's disease and cerebrovascular disease: is there a link? A neurosonological case-control study.

Authors:  Sandro Zambito Marsala; Manuela Gioulis; Michele Pistacchi; Cecilia Lo Cascio
Journal:  Neurol Sci       Date:  2016-07-09       Impact factor: 3.307

3.  Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease.

Authors:  Vikas Kotagal; Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey; Roger L Albin
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

4.  Diagnosis and referral delay in women with Parkinson's disease.

Authors:  Rachel Saunders-Pullman; Cuiling Wang; Kaili Stanley; Susan B Bressman
Journal:  Gend Med       Date:  2011-06

Review 5.  Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Authors:  L M Rubenstein; A DeLeo; E A Chrischilles
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

6.  The topography of brain damage at different stages of Parkinson's disease.

Authors:  Federica Agosta; Elisa Canu; Tanja Stojković; Michela Pievani; Aleksandra Tomić; Lidia Sarro; Nataša Dragašević; Massimiliano Copetti; Giancarlo Comi; Vladimir S Kostić; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2012-04-24       Impact factor: 5.038

7.  Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression.

Authors:  Richard B Dewey; Aanchal Taneja; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Ira Bernstein; Mustafa M Husain
Journal:  Cogn Behav Neurol       Date:  2012-09       Impact factor: 1.600

8.  LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease.

Authors:  Z Gan-Or; A Bar-Shira; A Mirelman; T Gurevich; M Kedmi; N Giladi; A Orr-Urtreger
Journal:  Neurogenetics       Date:  2009-05-21       Impact factor: 2.660

Review 9.  Parkinson disease and comorbid cerebrovascular disease.

Authors:  Wandana Nanhoe-Mahabier; Karlijn F de Laat; Jasper E Visser; Jan Zijlmans; Frank-Erik de Leeuw; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

10.  Neuropsychiatric symptoms in Parkinson's disease with mild cognitive impairment and dementia.

Authors:  Iracema Leroi; Hiranmayi Pantula; Kathryn McDonald; Vijay Harbishettar
Journal:  Parkinsons Dis       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.